Talphera, INC Form 4 insider transactions

Talphera Director Mark A. Wan acquired 5,100 shares of common stock and 30,700 stock options, with vesting contingent on continued service.

Director Joseph Todisco of Talphera, Inc. reported the acquisition of 5,100 shares of common stock and 30,700 stock options.

Talphera, Inc. director Abhinav Jain reported the acquisition of 5,100 shares of common stock and 30,700 stock options.

Talphera, Inc. director Stephen J. Hoffman acquired 5,100 shares of common stock and was granted an option for 30,700 shares.

Jill Marie Broadfoot, a Director at Talphera, Inc., acquired 5,100 shares of common stock and was granted an option for 30,700 shares.

Director Marina Bozilenko acquired 5,100 shares of common stock and 30,700 stock options in Talphera, Inc. (TLPH) on June 22, 2026.

Director Adrian Adams reported a transaction involving the acquisition of 5,100 shares of common stock and 30,700 stock options in Talphera, Inc.

Talphera, Inc. Chief Medical Officer Shakil Aslam reported a transaction involving the surrender of shares to cover tax withholdings.

Vincent J. Angotti, CEO of Talptera, Inc., reported a transaction involving the surrender of shares to cover tax withholdings related to Restricted Stock Unit (RSU) vesting.

Raffi Asadorian, Chief Financial Officer of Talphera, Inc., reported a transaction involving the surrender of shares to cover tax withholdings upon the vesting of Restricted Stock Units.

Talphera Inc. Chief Medical Officer Shakil Aslam reported a transaction involving the surrender of shares to cover tax withholdings.

Talphera's Chief Engineering Officer, Badri N. Dasu, reported a transaction involving the surrender of shares to cover tax withholdings upon RSU vesting.

Talphera's CEO, Vincent J. Angotti, acquired 213,310 shares of common stock at $0.586 per share through a pre-arranged PIPE transaction.

Nantahala Capital Management and its principals acquired over 4.2 million pre-funded warrants in Talphera, Inc., increasing their beneficial ownership.

TALPHERA, INC. CEO Vincent J. Angotti reported recent equity transactions including RSU vesting, share dispositions for tax, and a significant stock option grant.

Talphera's Chief Medical Officer, Shakil Aslam, acquired 35,000 shares of common stock and options for 205,000 shares.

Talphera's Chief Engineering Officer, Badri N. Dasu, reported recent stock transactions including RSU vesting, tax-related dispositions, and a new stock option grant.

Talphera's Chief Financial Officer, Raffi Asadorian, reported the vesting of restricted stock units and the grant of new stock options, increasing his beneficial ownership.

Talphera, Inc. Director Stephen J Hoffman acquired 4,267 restricted stock units and 25,600 stock options on October 23, 2025.

Talphera Director Mark Wan was granted 4,267 restricted stock units and options for 25,600 shares of common stock.

Talphera, Inc. director Marina Bozilenko received 4,267 restricted stock units and 25,600 stock options as equity compensation.

Talphera, Inc. Director Jill Marie Broadfoot acquired 4,267 restricted stock units and 25,600 stock options on October 23, 2025, as reported in a recent SEC filing.

Talphera, Inc. Director Adrian Adams acquired 4,267 restricted stock units and 25,600 stock options, increasing his beneficial ownership.

Talphera, Inc. Director Abhinav Jain was granted 4,267 restricted stock units and options for 25,600 shares of common stock, aligning his interests with shareholders.

Talphera, Inc. director Joseph Todisco received 6,397 restricted stock units and options to purchase 38,381 shares of common stock.

Chief Medical Officer Shakil Aslam reports disposition of shares to cover tax obligations related to vesting of RSUs.

Chief Engineering Officer Badri N Dasu reports acquisition of 15,000 common stock shares and options to purchase 80,000 shares of Talphera Inc.

Chief Medical Officer Shakil Aslam reports the acquisition of restricted stock units and a stock option grant from Talphera, Inc.

Raffi Asadorian, CFO of Talphera, Inc., reports the acquisition of 15,000 shares of common stock and options to purchase 80,000 shares.

CEO Vincent Angotti reports acquisition of Talphera shares and stock options on April 2, 2025.